Bart C De Jonghe
8PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 09, 2026
GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models.Caitlin Baumer-Harrison, Danya Aldaghma, Alex D White
|Jul 23, 2025
Hindbrain octadecaneuropeptide gliotransmission as a therapeutic target for energy balance control without nausea or emesis.Caroline E Geisler, Kylie S Chichura, Oleksandr Orativskyi
|Jun 18, 2025
Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models.Tito Borner, Allison M Pataro, Sarah A Doebley
|Dec 10, 2022
Peripherally restricted oxytocin is sufficient to reduce food intake and motivation, while CNS entry is required for locomotor and taste avoidance effects.Mohammed Asker, Jean-Philippe Krieger, Amber Liles
|Feb 07, 2022
Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.M Ghidewon, H S Wald, A D McKnight
|Apr 01, 2021
Olanzapine Administration Reduces Chemotherapy-Induced Nausea Behavior in Rats.Rosario B Jaime-Lara, Tito Borner, Ruby A Holland
Pageof 2
Frequent Collaborators
5 joint publications
Matthew R Hayes
3 joint publications
Tito Borner
3 joint publications
Robert P Doyle
2 joint publications
Tito Borner
2 joint publications
Caitlin Baumer-Harrison
1 joint publications
Ruby A Holland
1 joint publications
Huiyuan Zheng
1 joint publications
Linda Rinaman
1 joint publications
Rosario B Jaime-Lara
1 joint publications
Jean-Philippe Krieger
